Your browser doesn't support javascript.
loading
Glycocalyx-targeted therapy ameliorates age-related arterial dysfunction.
Machin, Daniel R; Trott, Daniel W; Gogulamudi, Venkateswara R; Islam, Md Torikul; Bloom, Samuel I; Vink, Hans; Lesniewski, Lisa A; Donato, Anthony J.
Afiliação
  • Machin DR; Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA. dmachin@fsu.edu.
  • Trott DW; Department of Nutrition and Integrative Physiology, Florida State University, Tallahassee, FL, 32306, USA. dmachin@fsu.edu.
  • Gogulamudi VR; Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
  • Islam MT; Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
  • Bloom SI; Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, UT, USA.
  • Vink H; Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, UT, USA.
  • Lesniewski LA; Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.
  • Donato AJ; MicroVascular Health Solutions LLC, Alpine, UT, USA.
Geroscience ; 45(4): 2351-2365, 2023 Aug.
Article em En | MEDLINE | ID: mdl-36787090

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artérias / Glicocálix Idioma: En Revista: Geroscience Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artérias / Glicocálix Idioma: En Revista: Geroscience Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos